TY - JOUR
T1 - The mechanism of intracerebral L-type voltage dependent calcium channels in drug addiction
AU - Jin, Shubo
AU - Shen, Fang
AU - Duan, Ying
AU - Li, Ming
AU - Sui, Nan
N1 - Publisher Copyright:
© 2016, Science Press. All right reserved.
PY - 2016/4/15
Y1 - 2016/4/15
N2 - Changes of intracellular calcium are the fundament of cell physiological function and the key factor in intracellular signal transduction and gene expression. Recently more studies have been focusing on the relationship between voltage dependent calcium channels (VDCCs) and drug addiction. A great deal of evidence suggests that L-type VDCCs (LTCCs), which are activated by membrane depolarization, play an important role in drug addiction by affecting the release of neurotransmitters, excitability of neurons, gene transcription and synaptic plasticity. LTCCs are divided into four subtypes: Cav1.1, Cav1.2, Cav1.3 and Cav1.4, according to the conduction of single channel and sensitivity to calcium antagonists and agonists. Among them Cav1.2 and Cav1.3 are mainly expressed in the central nervous system. It is reported that the increasing of intracellular calcium induced by LTCCs is crucial in physical dependence and withdrawal symptoms of addictive drugs such as morphine. In addition, the enhancement of cAMP-response element binding protein (CREB) and ryanodine receptor 2 (RyR2) induced by LTCCs on endoplasmic reticulum (ER) stimulate the release of calcium in cytoplasm, leading to a long-term increase in intracellular calcium. This relation might underlie the dependence and tolerance of nicotine. Moreover, it is reported that LTCCs also take part in nonsomatic signs of drug withdrawal. For example, intraperitoneal injection of LTCCs antagonists can reduce nonsomatic withdrawal symptoms in chronic nicotine-dependent rats, like anxiety, memory impartment and depression-like effects. Furthermore, recent researches also find that Cav1.2 and Cav1.3 play an important role in the acquisition and expression of cocaine-induced behavioral sensitization through different molecular mechanisms in specific brain regions. For instance, Cav1.3 in the ventral tegmental area (VTA) affects the development of cocaine sensitization by activating extracellular regulated protein kinases 2 (ERK2); While in the expression of cocaine sensitization, on the one hand, Cav1.2 opening in the nucleus accumbens (NAc) regulated by dopamine 1 (D1) receptor, activates its downstream Ca2+/calmodulin-dependent protein kinase II (CaMK II) and ERK2, leading to the phosphorylation at GluA1Ser831 of α-amino-3-hydroxy-5- methyl-4-isoxazole-propionic acid receptor (AMPAR) and the membrane insertion of AMPA receptor GluA1 subunit. This process needs the activation of Cav1.3 in the VTA. On the other hand, activation of Cav1.3 in the dorsal striatum (DS), which is regulated by D2 receptor, suppresses its downstream activation, including CREB, DARPP-32, Akt and GSK-3β, leading to the reduction of phosphorylation at GLuA1Ser845 and the expression level of membrane GluA1.Besides, LTCCs are also involved in the acquisition, expression and reinstatement of addiction memory. Recent studies indicate that LTCCs play different roles in different phases of addiction memory. For example, LTCCs in the VTA are involved in the acquisition of morphine conditioned place preference (CPP) by activating N-methyl-D-aspartate receptor (NMDAR); Whereas LTCCs in the NAc regulate development and expression of morphine CPP via interacting with the RyR2 which can induce the calcium release from the ER. Moreover, it has been demonstrated that the scaffold protein A-kinase anchor proteins79/150 (AKAP79/150) can anchor LTCCs to synaptic membranes, which might be a potential mechanism underlying the reinstatement of addiction memory induced by drugs. Therefore, in this review, we will focus on summarizing the role and the potential cellular and molecular mechanisms of LTCCs in drug addiction, with the expectation of expanding the perspectives onto further exploration of the neurobiological mechanisms of addiction memory.
AB - Changes of intracellular calcium are the fundament of cell physiological function and the key factor in intracellular signal transduction and gene expression. Recently more studies have been focusing on the relationship between voltage dependent calcium channels (VDCCs) and drug addiction. A great deal of evidence suggests that L-type VDCCs (LTCCs), which are activated by membrane depolarization, play an important role in drug addiction by affecting the release of neurotransmitters, excitability of neurons, gene transcription and synaptic plasticity. LTCCs are divided into four subtypes: Cav1.1, Cav1.2, Cav1.3 and Cav1.4, according to the conduction of single channel and sensitivity to calcium antagonists and agonists. Among them Cav1.2 and Cav1.3 are mainly expressed in the central nervous system. It is reported that the increasing of intracellular calcium induced by LTCCs is crucial in physical dependence and withdrawal symptoms of addictive drugs such as morphine. In addition, the enhancement of cAMP-response element binding protein (CREB) and ryanodine receptor 2 (RyR2) induced by LTCCs on endoplasmic reticulum (ER) stimulate the release of calcium in cytoplasm, leading to a long-term increase in intracellular calcium. This relation might underlie the dependence and tolerance of nicotine. Moreover, it is reported that LTCCs also take part in nonsomatic signs of drug withdrawal. For example, intraperitoneal injection of LTCCs antagonists can reduce nonsomatic withdrawal symptoms in chronic nicotine-dependent rats, like anxiety, memory impartment and depression-like effects. Furthermore, recent researches also find that Cav1.2 and Cav1.3 play an important role in the acquisition and expression of cocaine-induced behavioral sensitization through different molecular mechanisms in specific brain regions. For instance, Cav1.3 in the ventral tegmental area (VTA) affects the development of cocaine sensitization by activating extracellular regulated protein kinases 2 (ERK2); While in the expression of cocaine sensitization, on the one hand, Cav1.2 opening in the nucleus accumbens (NAc) regulated by dopamine 1 (D1) receptor, activates its downstream Ca2+/calmodulin-dependent protein kinase II (CaMK II) and ERK2, leading to the phosphorylation at GluA1Ser831 of α-amino-3-hydroxy-5- methyl-4-isoxazole-propionic acid receptor (AMPAR) and the membrane insertion of AMPA receptor GluA1 subunit. This process needs the activation of Cav1.3 in the VTA. On the other hand, activation of Cav1.3 in the dorsal striatum (DS), which is regulated by D2 receptor, suppresses its downstream activation, including CREB, DARPP-32, Akt and GSK-3β, leading to the reduction of phosphorylation at GLuA1Ser845 and the expression level of membrane GluA1.Besides, LTCCs are also involved in the acquisition, expression and reinstatement of addiction memory. Recent studies indicate that LTCCs play different roles in different phases of addiction memory. For example, LTCCs in the VTA are involved in the acquisition of morphine conditioned place preference (CPP) by activating N-methyl-D-aspartate receptor (NMDAR); Whereas LTCCs in the NAc regulate development and expression of morphine CPP via interacting with the RyR2 which can induce the calcium release from the ER. Moreover, it has been demonstrated that the scaffold protein A-kinase anchor proteins79/150 (AKAP79/150) can anchor LTCCs to synaptic membranes, which might be a potential mechanism underlying the reinstatement of addiction memory induced by drugs. Therefore, in this review, we will focus on summarizing the role and the potential cellular and molecular mechanisms of LTCCs in drug addiction, with the expectation of expanding the perspectives onto further exploration of the neurobiological mechanisms of addiction memory.
KW - Addiction memory
KW - Ca1.2
KW - Ca1.3
KW - LTCCs
KW - Synaptic plasticity
UR - http://www.scopus.com/inward/record.url?scp=85040679975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040679975&partnerID=8YFLogxK
U2 - 10.1360/N972015-01037
DO - 10.1360/N972015-01037
M3 - Article
AN - SCOPUS:85040679975
SN - 0023-074X
VL - 61
SP - 1173
EP - 1180
JO - Kexue Tongbao/Chinese Science Bulletin
JF - Kexue Tongbao/Chinese Science Bulletin
IS - 11
ER -